financetom
Business
financetom
/
Business
/
Reliance Jio Q2: Net profit up 12%; revenue growth at 5.6%
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Reliance Jio Q2: Net profit up 12%; revenue growth at 5.6%
Oct 30, 2020 11:55 AM

Reliance Jio has reported its second-quarter numbers. RIL's telecom & digital subsidiary's net profit rose 12.9 percent to Rs 2,844 crore from Rs 2,520 crore while revenue reported a growth of 5.6 percent to Rs 17,481 crore from Rs 16,557 crore when compared quarterly.

 Q4FY19Q1FY20Q2FY20Q3FY20Q4FY20Q1FY21Q2FY21
PAT (Rs cr)8408919901350233125202844
PAT QOQ %1.1%6.1%11.10%36.40%72.70%8.10%12.86%

 Jio Q4FY19Q1FY20Q2FY20Q3FY20Q4FY20Q1FY21Q2FY21
Rev (Rs cr)11106116791235413968148351655717481
Rev QOQ %7.0%5.16%5.80%13.06%6.21%11.60%5.58%

When compared to its peers, the revenue growth is a little lower than Bharti Airtel which grew at 7.4 percent. VI (Vodafone India) grew 1.2 percent in the same period.

The telecom giant has reported an ARPU (average revenue per user) at Rs 145 which is up 4.28 percent versus Rs 140 in the previous quarter.

The customer base now stands at 405.6 million subscribers with an addition of 7.3 million in the reported quarter.

The per capita wireless usage is approximately at 12 GB and 776 mins per month.

Disclosure: RIL, the promoter of Reliance Jio, also controls Network18, the parent company of CNBCTV18.com.

(Edited by : Abhishek Jha)

First Published:Oct 30, 2020 7:55 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Exclusive - US lawmaker seeks answers on FDA inspection of Musk's Neuralink
Exclusive - US lawmaker seeks answers on FDA inspection of Musk's Neuralink
Mar 26, 2024
WASHINGTON (Reuters) - A U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk's Neuralink before allowing the brain implant company to test its device in humans. Reuters reported last month that FDA inspectors found problems with record keeping and quality controls for animal experiments at Neuralink last June, less...
Elbit Systems Fourth-Quarter Earnings Decline as Expenses Increase Annually
Elbit Systems Fourth-Quarter Earnings Decline as Expenses Increase Annually
Mar 26, 2024
06:24 AM EDT, 03/26/2024 (MT Newswires) -- Elbit Systems ( ESLT ) reported mixed fourth-quarter results on Tuesday as costs related to the closure of a subsidiary weighed on the Israeli defense electronics company's earnings. Adjusted earnings came in at $1.56 a share for the December quarter, down from $1.71 a year earlier. The company attributed the decline to costs...
Karnalyte Resources Narrows Full-Year 2023 Net Loss YOY; Jumped Near 22% On Monday
Karnalyte Resources Narrows Full-Year 2023 Net Loss YOY; Jumped Near 22% On Monday
Mar 26, 2024
06:27 AM EDT, 03/26/2024 (MT Newswires) -- Karnalyte Resources Inc. ( KRLTF ) overnight Monday reported full-year 2023 net and comprehensive loss of $1.4 million, or $0.03 per share, narrowing from a loss of $1.7 million, or $0.04 per share, in 2022. As of Dec. 31, 2023, the company had cash of $2.3 million, a positive working capital of $2.1...
Gap Insider Sold Shares Worth $767,010, According to a Recent SEC Filing
Gap Insider Sold Shares Worth $767,010, According to a Recent SEC Filing
Mar 26, 2024
06:19 AM EDT, 03/26/2024 (MT Newswires) -- Mark Breitbard, President & CEO, Gap Brand, on March 22, 2024, sold 27,222 shares in Gap (GPS) for $767,010. Following the Form 4 filing with the SEC, Breitbard has control over a total of 123,985 shares of the company, with 123,985 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/39911/000003991124000100/xslF345X03/edgardoc.xml Price: 28.13, Change: +0.22, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved